OUR PRODUCTS

MOBILE APPS

GENERAL INFO

AIM

Stock ticker: ASE

PRICE

CHANGE

CAPITALIZATION

AIM ImmunoTech (AIM) Ownership - Who owns AIM ImmunoTech?

AIM ImmunoTech Inc is an immuno-pharma company focused on research and development of therapeutics to treat immune disorders and viral and cancer diseases... Show more

Get AI intraday signals

#MovingAverage #Momentum #MACD #Pattern #RSI #Stochastic #Aroon #Bollinger

Profile

Industry

N/A

Address

2117 SW Highway 484

Phone

+1 352 448-7797

Employees

Web

https://www.aimimmuno.com

Details

Group

Domestic Stock Funds

Fundamentals

AIM

Capitalization

7.04M

P/E Ratio

N/A

Risk (Beta)

N/A

Dividend Yield

N/A

Total Cash

N/A

Total Cash/Share

N/A

Total Debt

N/A

Total Debt/Equity

N/A

Projected Growth (PEG Ratio)

N/A

Revenue/Share (as % of the share price)

0.24%

Revenue

N/A

ROE

N/A

Book Value

N/A

P/B Ratio

2.89

Cash Flow

N/A

Earnings

N/A

Average Daily Volume YTD

N/A

Common Shares Outstanding - Security Level

N/A

Current Ratio

N/A

Current Revenue Per Employee

N/A

Dividends Per Share - Security

N/A

EBITDA

N/A

Float

N/A

Float - Current

N/A

Gross Income Margin

N/A

Revenue To Assets

N/A

Shares Held By Institutions

N/A

Shares Outstanding - Current

764K

Total Liabilities

N/A

Total Volume MTD

N/A

Value

N/A

Gain YTD

4551.515

View a ticker or compare two or three

Compare

Interact to see
Advertisement

A.I.Advisor

published price charts

A.I. Advisor

published General Information

General Information

a biopharmaceutical company, which engages in the clinical development of new drug therapies based on natural immune system enhancing technologies for the treatment of viral and immune based disorders

Industry Biotechnology